The United States Patent and Trademark Office recently issued patent 12,178,937, entitled “Compositions and Methods for Adhesion to Surfaces,” which constitutes the 10th.
RevBio announced that it has received a grant from the National Institutes of Health through its Helping to End Addiction Long-term Initiative, or.
RevBio announced that it has received approval from the U.S. Food and Drug Administration to commence a 20-patient clinical trial to assess the.
RevBio, Inc., announced that it has been awarded a $2 million Phase II Small Business Innovation Research (SBIR) grant from the National Institute.
RevBio announced that it has received a strategic investment from Pacific Dental Services (PDS) to support the clinical development of its bone adhesive.
